HomeProductsBioactive CompoundsMetabolic EnzymesElastaseAlvelestat
Chemical structure of CAS 848141-11-7

Alvelestat

CAS No.848141-11-7
MDL No.MFCD26960961
MFC25H22F3N5O4S
MW545.50
InChI KeyQNQZWEGMKJBHEM-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.848141-11-7
Product NameAlvelestat

Biological Targets

ELANE

Associated Conditions

hematopoietic and lymphoid cell neoplasm·chronic obstructive pulmonary disease·Bronchiectasis·cystic fibrosis·COVID-19
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.

Respiratory medicine • Vol. 106, Issue 4 • 2012
PMID: 22197578DOI: 10.1016/j.rmed.2011.10.020

Neutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors.

Future medicinal chemistry • Vol. 4, Issue 5 • 2012
PMID: 22458683DOI: 10.4155/fmc.12.17

AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase.

The Journal of pharmacology and experimental therapeutics • Vol. 339, Issue 1 • 2011
PMID: 21791628DOI: 10.1124/jpet.111.182139

Documentation

Similar Products